Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL2200390	恩格列净西格列汀二甲双胍缓释片	empagliflozin;metformin hydrochloride;sitagliptin phosphate	Tablet, extended release	Chemical Drugs(2.3)	New Drug Application	2022-06-16		Taizhou Yueyang Pharmaceutical Development Co Ltd			view